Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Tritschler

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Clinical significance of subsegmental pulmonary embolism: An ongoing controversyChristine Baumgartner, Tobias Tritschler
Intensive Care Medicine|September 3, 2013
Is the number of drugs independently associated with mortality?Tobias Tritschler, Bernhard Frey
Thrombosis Research|June 22, 2019
It's time for head-to-head trials with direct oral anticoagulantsTobias Tritschler, Lana A Castellucci
Blood Advances|February 14, 2019
Extended therapy for unprovoked venous thromboembolism: when is it indicated?Tobias Tritschler, Philip S Wells
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 8, 2022
Faizan Khan, Tobias Tritschler, Ryan Zarychanski
Journal of Epidemiology and Population Health|January 22, 2026
20 years of Pulmonary Embolism Severity Index: derivation, validation, and impact on patient careDrahomir Aujesky, Ibrahim Schaefer, Tobias Tritschler
Hamostaseologie|October 23, 2023
Subsegmental Pulmonary EmbolismChristine Baumgartner, Tobias Tritschler, Drahomir Aujesky
VASA. Zeitschrift Fur Gefasskrankheiten|September 26, 2025
Practice-changing evidence from academic trials in VTE: COBRRA, RENOVE, and API-CATStefano Barco, Tobias Tritschler, Marc Blondon
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 24, 2022
Antithrombotic agents in patients with COVID-19Faizan Khan, Tobias Tritschler, Ryan Zarychanski
Thrombosis Research|November 10, 2022
Subgroup analysis in randomized controlled trials: Useful or misleading?Tobias Tritschler, Parham Sadeghipour, Behnood Bikdeli
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Clinical significance of subsegmental pulmonary embolism: An ongoing controversyChristine Baumgartner, Tobias Tritschler
Intensive Care Medicine|September 3, 2013
Is the number of drugs independently associated with mortality?Tobias Tritschler, Bernhard Frey
Thrombosis Research|June 22, 2019
It's time for head-to-head trials with direct oral anticoagulantsTobias Tritschler, Lana A Castellucci
Blood Advances|February 14, 2019
Extended therapy for unprovoked venous thromboembolism: when is it indicated?Tobias Tritschler, Philip S Wells
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 8, 2022
Faizan Khan, Tobias Tritschler, Ryan Zarychanski
Journal of Epidemiology and Population Health|January 22, 2026
20 years of Pulmonary Embolism Severity Index: derivation, validation, and impact on patient careDrahomir Aujesky, Ibrahim Schaefer, Tobias Tritschler
Hamostaseologie|October 23, 2023
Subsegmental Pulmonary EmbolismChristine Baumgartner, Tobias Tritschler, Drahomir Aujesky
VASA. Zeitschrift Fur Gefasskrankheiten|September 26, 2025
Practice-changing evidence from academic trials in VTE: COBRRA, RENOVE, and API-CATStefano Barco, Tobias Tritschler, Marc Blondon
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 24, 2022
Antithrombotic agents in patients with COVID-19Faizan Khan, Tobias Tritschler, Ryan Zarychanski
Thrombosis Research|November 10, 2022
Subgroup analysis in randomized controlled trials: Useful or misleading?Tobias Tritschler, Parham Sadeghipour, Behnood Bikdeli
Pageof 9